FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 0 |
| Recalls | 1 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | June 24, 2026 |
Enforcement history
On 2026-06-24, Argus HQ recorded an FDA recall for Medtronic Navigation, Inc.-Boxborough, rated "high" severity in Argus HQ's classification: Medtronic Navigation, Inc.-Boxborough — Class II recall: Medtronic O-arm O2 Imaging System. Model Number: BI70002000.. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Medtronic Navigation, Inc.-Boxborough has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- Has Medtronic Navigation, Inc.-Boxborough had product recalls?
- Yes, 1 recall on file. See the full history below for each one.
- Is this FDA enforcement data for Medtronic Navigation, Inc.-Boxborough official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
- How many FDA actions has Medtronic Navigation, Inc.-Boxborough had?
- Argus HQ has recorded 1 FDA events for Medtronic Navigation, Inc.-Boxborough: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- What is the most recent FDA action against Medtronic Navigation, Inc.-Boxborough?
- The most recent FDA event Argus HQ has on file for Medtronic Navigation, Inc.-Boxborough is dated 2026-06-24, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Medtronic Navigation, Inc.-Boxborough vs Medline Industries, LP
- Medtronic Navigation, Inc.-Boxborough vs ARROW INTERNATIONAL, LLC
- Medtronic Navigation, Inc.-Boxborough vs Stryker Sustainability Solutions
- Medtronic Navigation, Inc.-Boxborough vs Guardian Drug Co. Inc.
- Medtronic Navigation, Inc.-Boxborough vs B BRAUN MEDICAL INC
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Actions Against Medtronic Navigation, Inc.-Boxborough. Digital Empire LLC. Retrieved from https://argushq.ai/company/medtronic-navigation-inc-boxborough
"FDA Actions Against Medtronic Navigation, Inc.-Boxborough." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/medtronic-navigation-inc-boxborough.
Argus HQ Research. "FDA Actions Against Medtronic Navigation, Inc.-Boxborough." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/medtronic-navigation-inc-boxborough.
@misc{argushq_argushq_ai_company_medtronic_navigation_inc_boxborough_2026,
title = {FDA Actions Against Medtronic Navigation, Inc.-Boxborough},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/medtronic-navigation-inc-boxborough},
note = {Accessed: July 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

